HIGHLIGHTS
- who: Gerardo Montalvo Zurbia-Flores et al. from the The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford , DG, UK have published the Article: Chikungunya Virus: Priority Pathogen or Passing Trend?, in the Journal: Vaccines 2023, 11, 568. of /2023/
- what: This study reported that the attack rates of DENV, ZIKV, and CHIKV were of 40.99, 58.38, and 29.72 cases per 100,000 inhabitants, respectively, between December 2015 and February 2016 .
SUMMARY
Notwithstanding the promising results of initial vaccine candidates, the development of CHIKV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.